SUNNYVALE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA) [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...
SAVANNAH, GA, UNITED STATES, February 25, 2026 /EINPresswire.com/ — Morph Services, Inc. today announced that its largest client deployment to date is now ...
BioCardia (BCDA) announced the commercial availability of its Morph DNA steerable introducer product family, currently utilized in the Company’s ongoing cell-therapy clinical trials. “Our team is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results